Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun capsule real-world study in chronic atrophic gastritis
ChiCTR2300071902Phase 4Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of weifuchun in atrophic gastritis (AG) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoint: Histopathology scores. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
weifuchun
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on ChiCTR2300071902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071902.